All Posts
Determination of “borderline resectable” pancreatic cancer – A global assessment of 30 shades of grey
8 Aug, 2023 | 13:22h | UTC
Commentary on Twitter
What is BORDERLINE respectable?! ?
A global assessment of 30 shades of grey ???
? Interobserver variability among radiologists and surgeons globally is high
?⚖️ Central review of images required for quality control initiativeshttps://t.co/Z2G1cInZ5f pic.twitter.com/mlucwMT5f9
— Giovanni Marchegiani (@Gio_Marchegiani) July 30, 2023
Consensus Paper | Minimally invasive pancreatic surgery
8 Aug, 2023 | 13:20h | UTC
Review | Management of hypocalcemia in the critically ill
8 Aug, 2023 | 13:19h | UTCManagement of hypocalcaemia in the critically ill – Current Opinion in Critical Care
Review | Regional anesthesia in the emergency department outside the operating theatre
8 Aug, 2023 | 13:17h | UTC
Review | Local anesthetic adjuncts for peripheral nerve blockade
8 Aug, 2023 | 13:16h | UTCLocal anaesthetic adjuncts for peripheral nerve blockade – Current Opinion in Anaesthesiology
Cohort Study | Clozapine, but not olanzapine or quetiapine, linked with higher perimyocarditis and heart failure risk
8 Aug, 2023 | 13:14h | UTC
Nationwide Study | Examining survival rates and risk factors in 237 drowned patients receiving ECMO
8 Aug, 2023 | 13:13h | UTC
Systematic Review | Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer
8 Aug, 2023 | 13:11h | UTCPegylated liposomal doxorubicin for relapsed epithelial ovarian cancer – Cochrane Library
M-A | The global prevalence of human fascioliasis
8 Aug, 2023 | 13:10h | UTC
Cohort Study | Potential negative survival impact of PPI and palbociclib co-administration in breast cancer patients
8 Aug, 2023 | 13:07h | UTC
Clinical Trial Update | Long-term Givosiran treatment shows sustained acute hepatic porphyria symptom improvement
8 Aug, 2023 | 13:05h | UTCOriginal Study: Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria – New England Journal of Medicine
NICE Updated Guideline | Venous thromboembolic diseases
7 Aug, 2023 | 15:05h | UTC
Review | Management of worsening heart failure with reduced ejection fraction
7 Aug, 2023 | 15:03h | UTC
Commentary on Twitter
How do you manage patients with worsening #HFrEF? This review by @SJGreene_md, @JavedButler1 and team provides the latest evidence-based guidance for the medical management of this high-risk population. https://t.co/REAqsrHDjI#JACC #CardioTwitter @ShelleyZieroth @DCRINews pic.twitter.com/rZYD25vCoG
— JACC Journals (@JACCJournals) August 5, 2023
Cohort Study | High-sensitivity troponin’s role in assessing MI and CV death risk in stable CAD patients
7 Aug, 2023 | 15:01h | UTCHigh-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentaries:
High-Sensitivity Troponin Assays May Stratify Risk in Chronic CAD – TCTMD
Commentary on Twitter
In patients with chronic CAD, an elevated #troponin identifies those more likely to have MI or CV death. Routine troponin testing in this setting could inform patient selection for additional treatment. https://t.co/T4HfidPwOA#JACC #cvCAD #CardioTwitter #cvPrev #cvMI pic.twitter.com/2IOU8jsFPj
— JACC Journals (@JACCJournals) August 1, 2023
Survey | The manifold costs of being a non-native English speaker in science
7 Aug, 2023 | 15:00h | UTCThe manifold costs of being a non-native English speaker in science – PLOS Biology
Commentary from the author: Non-native English speaking scientists work much harder just to keep up, global research reveals – The Conversation
News Releases:
The cost of being a non-native English speaker in science – PLOS
Science language barrier could cost countless careers – University of Queensland
Commentary on Twitter
Some potential solutions to reducing disadvantages for non-native English speakers in publishing & conferences
By @tatsuya_amano & colleagues from their seminal @PLOSBiology paperhttps://t.co/luBndai3FQ @PLOS pic.twitter.com/68x6rZBMW4
— Madhu Pai, MD, PhD (@paimadhu) August 5, 2023
Opinion | Regulating direct-to-consumer polygenic risk scores
7 Aug, 2023 | 14:59h | UTCRegulating Direct-to-Consumer Polygenic Risk Scores – JAMA (free for a limited period)
Perspective | The paradoxical decline of geriatric medicine as a profession
7 Aug, 2023 | 14:57h | UTCThe Paradoxical Decline of Geriatric Medicine as a Profession – JAMA (free for a limited period)
Commentary on Twitter
Viewpoint: author Jerry Gurwitz discusses the attrition of geriatric medicine as a profession, attributing it in part to societal attitudes about aging and compounded by the negative effects of lower compensation and lack of career prestige. https://t.co/5uydZzMrqS pic.twitter.com/RFY5grczQ4
— JAMA (@JAMA_current) August 4, 2023
Expert Panel | Assessment and management of older adults undergoing percutaneous coronary intervention
7 Aug, 2023 | 14:55h | UTC
A novel comprehensive algorithm for evaluation of pediatric ICU patients with new fever or instability
7 Aug, 2023 | 14:53h | UTC
ESPEN guideline on nutritional support for polymorbid medical inpatients
7 Aug, 2023 | 14:52h | UTCESPEN guideline on nutritional support for polymorbid medical inpatients – Clinical Nutrition
Phase 2 Trials | Selective NaV1.8 inhibitor, VX-548, shows potential in acute postoperative pain management
7 Aug, 2023 | 14:51h | UTCSelective Inhibition of NaV1.8 with VX-548 for Acute Pain – New England Journal of Medicine (link to abstract – $ for full-text)
Video Summary: Selective Inhibition of NaV1.8 for Acute Pain | NEJM
Commentaries:
High-Dose VX-548 Reduces Acute Pain Post-Surgery – HCP Live
High-Dose VX-548 Reduces Acute Pain Over 48 Hours – HealthDay
Commentary on Twitter
Original Article: Selective Inhibition of NaV1.8 with VX-548 for Acute Pain https://t.co/ogmEx6FNKo#surgery pic.twitter.com/0FpipA1xey
— NEJM (@NEJM) August 5, 2023
M-A | Efficacy and safety of supraclavicular versus infraclavicular approach for subclavian vein catheterization
7 Aug, 2023 | 14:49h | UTC
Systematic review informing the 2022 EULAR recommendations for the management of ANCA-associated vasculitis
7 Aug, 2023 | 14:47h | UTCGuideline: EULAR recommendations for the management of ANCA-associated vasculitis
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
7 Aug, 2023 | 14:45h | UTC
Do-it-yourself automated insulin delivery: a health-care practitioner user’s guide
7 Aug, 2023 | 14:44h | UTC